By restructuring a typical chemotherapy drug, scientists elevated its efficiency by 20,000 occasions.
In a big step ahead for most cancers remedy, researchers at Northwestern College have redesigned the molecular construction of a well known chemotherapy drug, significantly rising its solubility, effectiveness, and security.
For this examine, the scientists created the drug totally from scratch as a spherical nucleic acid (SNA), a nanoscale construction that includes the drug into DNA strands surrounding tiny spheres. This progressive design transforms a compound that usually dissolves poorly and works weakly right into a extremely potent, exactly focused therapy that spares wholesome cells from injury.
When examined in a small animal mannequin of acute myeloid leukemia (AML), an aggressive and hard-to-treat blood most cancers, the SNA-based model confirmed exceptional outcomes. It entered leukemia cells 12.5 occasions extra effectively, destroyed them as much as 20,000 occasions extra successfully, and slowed most cancers development by an element of 59, all with out inflicting noticeable negative effects.
In line with the researchers, this achievement highlights the rising promise of structural nanomedicine, an rising space of analysis the place scientists rigorously design each the construction and composition of nanomedicines to manage how they behave contained in the physique. With seven SNA-based therapies already in medical trials, this strategy might pave the best way for superior vaccines and new remedies for most cancers, infectious illnesses, neurodegenerative problems, and autoimmune situations.
The findings have been not too long ago revealed within the journal ACS Nano.
A Breakthrough with Medical Promise
“In animal fashions, we demonstrated that we are able to cease tumors of their tracks,” stated Northwestern’s Chad A. Mirkin, who led the examine. “If this interprets to human sufferers, it is a actually thrilling advance. It could imply simpler chemotherapy, higher response charges and fewer negative effects. That is all the time the objective with any type of most cancers therapy.”
A pioneer in chemistry and nanomedicine, Mirkin is the George B. Rathmann Professor of Chemistry, Chemical and Organic Engineering, Biomedical Engineering, Supplies Science and Engineering and Drugs at Northwestern, the place he has appointments within the Weinberg Faculty of Arts and Sciences, McCormick College of Engineering and Feinberg College of Drugs. He is also the founding director of the Worldwide Institute for Nanotechnology and a member of the Robert H. Lurie Complete Most cancers Middle of Northwestern College.
Credit score: Mirkin Analysis Group/Northwestern College
For the brand new examine, Mirkin and his crew centered on the standard chemotherapy drug 5-fluorouracil (5-Fu), which frequently fails to succeed in most cancers cells effectively. And, as a result of it additionally assaults wholesome tissue, 5-Fu causes myriad negative effects, together with nausea, fatigue and, in uncommon instances, even coronary heart failure.
In line with Mirkin, the drug itself isn’t the issue — it is how the physique processes it. 5-Fu is poorly soluble, which means lower than 1% of it dissolves in lots of organic fluids. Most medication have to dissolve within the bloodstream earlier than they will journey by means of the physique to enter cells. If a drug is poorly soluble, it clumps or retains a strong type, and the physique can’t take in it effectively.
“Everyone knows that chemotherapy is commonly horribly poisonous,” Mirkin stated. “However lots of people do not understand it is also usually poorly soluble, so we’ve got to seek out methods to rework it into water soluble types and ship it successfully.”
The SNA Resolution
To develop a simpler supply system, Mirkin and his crew turned to SNAs. Invented and developed by Mirkin at Northwestern, SNAs are globular nanostructures with a nanoparticle core surrounded by a dense shell of DNA or RNA. In earlier research, Mirkin found that cells acknowledge SNAs and invite them inside. Within the new examine, his crew constructed new SNAs with the chemotherapy chemically integrated into the DNA strands.
“Most cells have scavenger receptors on their surfaces,” Mirkin stated. “However myeloid cells overexpress these receptors, so there are much more of them. In the event that they acknowledge a molecule, then they may pull it into the cell. As an alternative of getting to pressure their approach into cells, SNAs are naturally taken up by these receptors.”
As Mirkin and his crew suspected, the structural redesign fully modified how 5-Fu interacted with the most cancers cells. Not like with free-floating, unstructured chemotherapy molecules, the myeloid cells simply acknowledged and absorbed the SNA type. As soon as inside, enzymes broke down the DNA shell to launch the drug molecules, which killed the most cancers cell from inside.
Within the mouse experiments, the remedy eradicated the leukemia cells to close completion within the blood and spleen and considerably prolonged survival. And, as a result of the SNAs selectively focused AML cells, wholesome tissues remained unhurt.
“At this time’s chemotherapeutics kill every part they encounter,” Mirkin stated. “So, they kill the most cancers cells but in addition lots of wholesome cells. Our structural nanomedicine preferentially seeks out the myeloid cells. As an alternative of overwhelming the entire physique with chemotherapy, it delivers a better, extra centered dose precisely the place it is wanted.”
Subsequent, Mirkin’s crew plans to check the brand new technique in a bigger cohort of small animal fashions, then transfer to a bigger animal mannequin and, finally, in human medical trials, as soon as funding is secured.
Reference: “Chemotherapeutic Spherical Nucleic Acids” by Taokun Luo, Younger Jun Kim, Zhenyu Han, Jeongmin Hwang, Sneha Kumari, Vinzenz Mayer, Alex Cushing, Roger A. Romero and Chad A. Mirkin, 29 October 2025, ACS Nano.
DOI: 10.1021/acsnano.5c16609
Funding: Nationwide Most cancers Institute, Nationwide Institute of Diabetes and Digestive and Kidney Ailments
